{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:20:57Z","timestamp":1790655657664,"version":"4.1.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010380","name":"Stiftung Universit\u00e4tsmedizin Essen","doi-asserted-by":"publisher","award":["2022 4699 112"],"award-info":[{"award-number":["2022 4699 112"]}],"id":[{"id":"10.13039\/501100010380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Albumin, as the most abundant plasma protein, represents a target structure for both drug and physicochemical therapeutic approaches to eliminate uraemic toxins more efficiently. Potentially, this approach could reduce mortality of haemodialysis patients. However, little is known about albumin functional properties in these patients and its alteration by haemodialysis treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The binding and detoxification efficiency of albumin were assessed by electron paramagnetic resonance spectroscopy using a spin-labelled fatty acid. Binding efficiency (BE) reflects strength and amount of bound fatty acids under certain ethanol concentration. Detoxification efficiency (DTE) reflects the molecular flexibility of the patient's albumin molecule, thus the ability to change the conformation depending on ethanol concentration. Percentage of BE and DTE are depicted in relation to healthy individuals (100%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifty-eight patients (59% male, median age 68\u00a0years, median time on haemodialysis 32\u00a0months) were included in the study. Before haemodialysis treatment, albumin binding and detoxification efficiency were substantially below healthy individuals [median BE 52% (interquartile range, IQR, 45%\u201359%); median DTE 38% (IQR 32\u201349%)]. After haemodialysis treatment, median BE and DTE significantly decreased [BE 28% (IQR 20\u201341%); DTE 11% (IQR 7%\u201327%; P\u00a0&amp;lt;\u00a0.001)]. BE and DTE decline after haemodialysis was not dependent on age, sex or treatment modalities, but was to a certain extent on the level of non-esterified fatty acids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Albumin binding and detoxification efficiency of fatty acids in maintenance haemodialysis patients were substantially below those in healthy individuals and even declined after dialysis treatment. These findings might be helpful when considering new therapeutic approaches in maintenance haemodialysis patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfad133","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T08:13:48Z","timestamp":1690964028000},"page":"215-221","source":"Crossref","is-referenced-by-count":7,"title":["Binding and detoxification efficiency of albumin decline after haemodialysis"],"prefix":"10.1093","volume":"39","author":[{"given":"Kristina","family":"Boss","sequence":"first","affiliation":[{"name":"Department of Nephrology, University Hospital Essen, University Duisburg-Essen , Essen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Waterstradt","sequence":"additional","affiliation":[{"name":"MedInnovation GmbH , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Schnurr","sequence":"additional","affiliation":[{"name":"MedInnovation GmbH , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margret","family":"Paar","sequence":"additional","affiliation":[{"name":"Division of Medicinal Chemistry, Otto Loewi Research Center, Medical University of Graz , Graz , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Stolpe","sequence":"additional","affiliation":[{"name":"Institute of Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University Duisburg-Essen , Essen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Ickerott","sequence":"additional","affiliation":[{"name":"Gemeinschaftspraxis f\u00fcr Nieren- und Hochdruckkrankheiten Essen-Steele , Essen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Wieneke","sequence":"additional","affiliation":[{"name":"Dialyse- und Lipid-Zentrum Nordrhein , Essen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Spitth\u00f6ver","sequence":"additional","affiliation":[{"name":"Dialyse- und Lipid-Zentrum Nordrhein , Essen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Oettl","sequence":"additional","affiliation":[{"name":"Division of Medicinal Chemistry, Otto Loewi Research Center, Medical University of Graz , Graz , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kribben","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Essen, University Duisburg-Essen , Essen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"2024013104475567500_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol Aspects Med"},{"key":"2024013104475567500_bib2","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.xphs.2022.03.005","article-title":"Therapeutic solutions of human albumin\u2014the possible effect of process-induced molecular alterations on clinical efficacy and safety","volume":"111","author":"Farrugia","year":"2022","journal-title":"J Pharm Sci"},{"key":"2024013104475567500_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000515825","article-title":"Extracorporeal albumin dialysis in liver failure with MARS and SPAD: a randomized crossover trial","volume":"51","author":"Wallon","year":"2022","journal-title":"Blood Purif"},{"key":"2024013104475567500_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MCC.0000000000000584","article-title":"Artificial liver support in acute and acute-on-chronic liver failure","volume":"25","author":"Larsen","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"2024013104475567500_bib5","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/gutjnl-2019-318843","article-title":"Albumin in decompensated cirrhosis: new concepts and perspectives","volume":"69","author":"Bernardi","year":"2020","journal-title":"Gut"},{"key":"2024013104475567500_bib6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s42003-021-02269-w","article-title":"Albumin in patients with liver disease shows an altered conformation","volume":"4","author":"Paar","year":"2021","journal-title":"Commun Biol"},{"key":"2024013104475567500_bib7","doi-asserted-by":"crossref","first-page":"e0192268","DOI":"10.1371\/journal.pone.0192268","article-title":"Alterations in conformational state of albumin in plasma in chronic hemodialyzed patients","volume":"13","author":"Pieniazek","year":"2018","journal-title":"PLoS One"},{"key":"2024013104475567500_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/membranes12030261","article-title":"Interaction of human serum albumin with uremic toxins: the need of new strategies aiming at uremic toxins removal","volume":"12","author":"Zare","year":"2022","journal-title":"Membranes (Basel)"},{"key":"2024013104475567500_bib9","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/ndt\/gfn002","article-title":"Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition","volume":"23","author":"Nishio","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2024013104475567500_bib10","first-page":"477","article-title":"Albumin-dialysis but not conventional hemodialysis increases the reduced albumin-binding capacity in end-stage renal failure","volume":"27","author":"Mitzner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"2024013104475567500_bib11","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/ndt\/gfr616","article-title":"Albumin-binding capacity (ABiC) is reduced in patients with chronic kidney disease along with an accumulation of protein-bound uraemic toxins","volume":"27","author":"Klammt","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2024013104475567500_bib12"},{"key":"2024013104475567500_bib13","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1373\/clinchem.2006.073148","article-title":"Electron spin resonance spectroscopy of serum albumin: a novel new test for cancer diagnosis and monitoring","volume":"52","author":"Kazmierczak","year":"2006","journal-title":"Clin Chem"},{"key":"2024013104475567500_bib14","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/hep.31798","article-title":"Determination of effective albumin in patients with decompensated cirrhosis: clinical and prognostic implications","volume":"74","author":"Baldassarre","year":"2021","journal-title":"Hepatology"},{"key":"2024013104475567500_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.22913","article-title":"Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality","volume":"50","author":"Jalan","year":"2009","journal-title":"Hepatology"},{"key":"2024013104475567500_bib16","volume-title":"All about Albumin. Biochemistry, Genetics, and Medical Applications","author":"Peters","year":"1995"},{"key":"2024013104475567500_bib17","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1023\/A:1013391001141","article-title":"In vitro and in vivo properties of recombinant human serum albumin from Pichia pastoris purified by a method of short processing time","volume":"18","author":"Watanabe","year":"2001","journal-title":"Pharm Res"},{"key":"2024013104475567500_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/0391398820961780","article-title":"Comparison of changes in albumin binding capacity during hemodiafiltration or hemodialysis with middle cut off membranes","volume":"44","author":"Koball","year":"2021","journal-title":"Int J Artif Organs"},{"key":"2024013104475567500_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/nu9060548","article-title":"Dialysis procedures alter metabolic conditions","volume":"9","author":"Stegmayr","year":"2017","journal-title":"Nutrients"},{"key":"2024013104475567500_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/08860220600778936","article-title":"Effects of low molecular weight heparin on the frequencies of intradialytic arrhythmias in hemodialysis patients","volume":"28","author":"Miyauchi","year":"2006","journal-title":"Ren Fail"},{"key":"2024013104475567500_bib21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1525-139X.2009.00597.x","article-title":"Lipoprotein lipase disturbances induced by uremia and hemodialysis","volume":"22","author":"Stegmayr","year":"2009","journal-title":"Semin Dial"},{"key":"2024013104475567500_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2362.1986.tb01302.x","article-title":"Warfarin binding to plasma albumin, measured in patients and related to fatty acid concentrations","volume":"16","author":"Larsen","year":"1986","journal-title":"Eur J Clin Invest"},{"key":"2024013104475567500_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/jth.12771","article-title":"Plasma free fatty acid levels influence Zn(2+)-dependent histidine-rich glycoprotein-heparin interactions via an allosteric switch on serum albumin","volume":"13","author":"Kassaar","year":"2015","journal-title":"J Thromb Haemost"},{"key":"2024013104475567500_bib24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jmb.2006.06.028","article-title":"Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis","volume":"361","author":"Simard","year":"2006","journal-title":"J Mol Biol"},{"key":"2024013104475567500_bib25","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.3390\/medicina58121780","article-title":"Impact of albumin binding function on pharmacokinetics and pharmacodynamics of furosemide","volume":"58","author":"Klinkmann","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"2024013104475567500_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2017.09.018","article-title":"Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: hope or pipe dream?","volume":"144","author":"Florens","year":"2018","journal-title":"Biochimie"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfad133\/51146802\/gfad133.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/39\/2\/215\/56437515\/gfad133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/39\/2\/215\/56437515\/gfad133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:15:06Z","timestamp":1706660106000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/39\/2\/215\/7240156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,8,9]]},"published-print":{"date-parts":[[2024,1,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfad133","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,8,9]]}}}